Science News
from research organizations

From chick to bedside: Removing the Wnt barrier

Date:
March 5, 2015
Source:
Baylor College of Medicine
Summary:
Kick starting a process that might repair the damage done in cerebral palsy and multiple sclerosis could begin with disabling a driver that helps block regeneration, say researchers.
Share:
FULL STORY

Kick starting a process that might repair the damage done in cerebral palsy and multiple sclerosis could begin with disabling a driver that helps block regeneration, said Baylor College of Medicine researchers in a report that appears in the journal Neuron.

When an infant is deprived of oxygen during or shortly after birth, the brain's white matter -- home to the myelin-making oligodendrocytes -- is damaged. Without myelin, the messages between nerve cells are interrupted or slowed. Similarly, the myelin sheath that covers nerves degenerates in multiple sclerosis, again interrupting the message that travels from neuron to neuron.

Cerebral palsy is increasing in recent years, with approximately 12,000 cases diagnosed annually. As more infants' lives are saved at earlier stages in the development, the risk of damage from lack of oxygen to the white matter of the brain increases. That kind of injury is the cause of cerebral palsy.

"Yet, those lesions in the white matter are populated by oligodendrocyte progenitors sitting in suspended animation," said Dr. Benjamin Deneen, associate professor in the Stem Cells and Regenerative Medicine Center at Baylor and the Center for Cell and Gene Therapy at Baylor, Texas Children's Hospital and Houston Methodist Hospital and corresponding author of the report. "The cells that are supposed to be making myelin are not doing it. If you could coax those cells to differentiate, you might have something."

Cells that differentiate are mature and can carry out their prescribed function.

Previously, collaborators at the University of California San Francisco had shown that Wnt signaling pathways are present at high levels in oligodendrocyte precursors, and Wnt blocks the ability of cells to differentiate.

Yet how did the Wnt signaling pathway get involved?

Dr. Hyun Kyoung Lee, a postdoctoral fellow in Deneen's laboratory at Baylor, began to uncover the answer, using chicks and their development as an experimental model.

"We knew a protein called Daam2 is important for Wnt signaling and receptor clustering of the Wnt complex," said Lee. "How does it do that?"

Using a variety of techniques including a hypoxia chamber that caused damage to the white matter, she and her colleagues showed that Daam2 interacts with another protein called PIP5K(inase) to allow the clustering that promotes Wnt signaling and prevents differentiation of the oligodendrocyte precursor.

In studies in two different mouse models -- one that mimicked the damage of cerebral palsy and the other, multiple sclerosis -- they found that those mice that lacked Daam2 had accelerated oligodendrocyte differentiation during development. In addition, the lack or reduction in activity of PIP5K (which interacts with Daam2 at the membrane level) also reduces differentiation of the oligodendrocyte precursors.

They also found that Daam2/PIP5K are expressed in the "suspended" oligodendrocyte precursors in the human neonatal brain after hypoxic injury, directly implicating this mechanism in neonatal white matter injury.

When they used a drug that inhibited PIP5K in a mouse brain injury model activated by a lack of oxygen, they saw differentiation of the oligodendrocyte precursors and increased myelination or formation of the nerve sheath.

While the drug could not be used in people, this finding presents a target for future drug development, said Deneen.

"There is no current treatment for cerebral palsy," said Deneen. "We need to find a drug that interrupts the Daam2/PIP5K interaction."


Story Source:

Materials provided by Baylor College of Medicine. Note: Content may be edited for style and length.


Journal Reference:

  1. Hyun Kyoung Lee, Lesley S. Chaboub, Wenyi Zhu, Daniel Zollinger, Matthew N. Rasband, Stephen P.J. Fancy, Benjamin Deneen. Daam2-PIP5K Is a Regulatory Pathway for Wnt Signaling and Therapeutic Target for Remyelination in the CNS. Neuron, 2015; DOI: 10.1016/j.neuron.2015.02.024

Cite This Page:

Baylor College of Medicine. "From chick to bedside: Removing the Wnt barrier." ScienceDaily. ScienceDaily, 5 March 2015. <www.sciencedaily.com/releases/2015/03/150305125518.htm>.
Baylor College of Medicine. (2015, March 5). From chick to bedside: Removing the Wnt barrier. ScienceDaily. Retrieved May 28, 2017 from www.sciencedaily.com/releases/2015/03/150305125518.htm
Baylor College of Medicine. "From chick to bedside: Removing the Wnt barrier." ScienceDaily. www.sciencedaily.com/releases/2015/03/150305125518.htm (accessed May 28, 2017).

RELATED STORIES